Rise and shine, everyone. The middle of the week is upon us. Have heart, though. You made it this far, so why not hang on for another couple of days, yes? And what better way to make the time fly than to keep busy. So grab that cup of stimulation — our flavor today boasts the aroma of blueberries — and get started. Meanwhile, do keep us in mind if you hear anything interesting. Have a smashing day …
Jazz Pharmaceuticals (JAZZ) agreed to pay $57 million to resolve a federal investigation into its financial support of charities that offer assistance to Medicare patients seeking help to cover out-of-pocket drug costs, according to a regulatory filing (see page 19). Jazz is among more than a dozen drug makers that have disclosed receiving subpoenas seeking information related to their support of patient-assistance charities. In December, United Therapeutics paid $210 million to resolve charges of paying kickbacks to Medicare patients through an ostensibly independent charity.
About the Author Reprints
